Literature DB >> 14564087

Life style and cardiovascular risk factors in the Japanese population--from an epidemiological survey on serum lipid levels in Japan 1990 part 2: association of lipid parameters with hypertension.

Akira Yamamoto1, Hitomi Temba, Hiroshi Horibe, Hiroshi Mabuchi, Yasushi Saito, Yuji Matsuzawa, Toru Kita, Haruo Nakamura.   

Abstract

The importance of metabolic syndrome as a risk factor of coronary artery disease (CAD) has recently become more and more recognized. In view of such a background, changes in cholesterol and other lipid parameters in the Japanese population associated with excess body weight and hypertension were analyzed in this study based on data obtained in an epidemiological survey carried out in 1990. Hypertension was closely associated with a higher body mass index (BMI). Among the lipid parameters, triglyceride (TG) and non-HDL-C (total cholesterol minus HDL-cholesterol) levels showed remarkable differences between hypertensive and normotensive subjects, with a greater statistical significance than LDL-cholesterol (LDL-C) levels. Changes in lipid parameters in the presence of hypertension were mostly associated with an increase in BMI in younger men aged 20-39, while increases in TG levels took place independently of excess body weight in middle-aged (40-59-year old) men. Considering that hypertension is a common and the greatest risk factor in the Japanese population, TG and non-HDL-C appear to be more important than LDL-C as major lipid parameters related to atherogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564087     DOI: 10.5551/jat.10.176

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  1 in total

1.  Depressive symptoms and serum lipid levels in young adult women.

Authors:  Carolyn Y Fang; Brian L Egleston; Kelley Pettee Gabriel; Victor J Stevens; Peter O Kwiterovich; Linda G Snetselaar; Margaret L Longacre; Joanne F Dorgan
Journal:  J Behav Med       Date:  2012-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.